The Patent Finder

Resverlogix Corp.

Also on record
Records under this name other than the patents Resverlogix Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 17 patents it holds.

Back to Resverlogix Corp.

PatentTitleStatus Expires Confidence
US 8,410,109Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
Lapsed on the fee record
Ended Apr 2, 2025 · From the USPTO record
Lapsed on the fee recordEnded Apr 2, 2025From the USPTO record
US 10,882,828Anti-inflammatory agents
Lapsed on the fee record
Ended Jan 5, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jan 5, 2025From the USPTO record
US 8,242,130Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
Lapsed on the fee record
Ended Aug 14, 2024 · From the USPTO record
Lapsed on the fee recordEnded Aug 14, 2024From the USPTO record
US 8,242,144Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
Lapsed on the fee record
Ended Aug 14, 2024 · From the USPTO record
Lapsed on the fee recordEnded Aug 14, 2024From the USPTO record
US 9,278,940Cyclic amines as bromodomain inhibitors
Formerly held
Lapsed on the fee record
Ended Mar 8, 2024 · From the USPTO record
Lapsed on the fee recordEnded Mar 8, 2024From the USPTO record
US 9,271,978Heterocyclic compounds as bromodomain inhibitors
Formerly held
Lapsed on the fee record
Ended Mar 1, 2024 · From the USPTO record
Lapsed on the fee recordEnded Mar 1, 2024From the USPTO record
US 9,238,640Anti-inflammatory agents
Lapsed on the fee record
Ended Jan 19, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jan 19, 2024From the USPTO record
US 8,093,273Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
Lapsed on the fee record
Ended Jan 10, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jan 10, 2024From the USPTO record
US 9,073,878Cyclic amines as bromodomain inhibitors
Formerly held
Lapsed on the fee record
Ended Jul 7, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jul 7, 2023From the USPTO record
US 10,231,953Inhibitors of bromodomains
Formerly held
Lapsed on the fee record
Ended Mar 19, 2023 · From the USPTO record
Lapsed on the fee recordEnded Mar 19, 2023From the USPTO record
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited